Bi-phasic change in BDNF gene expression following antidepressant drug treatment

Neuropharmacology

Volumn 44, Issue 7, 2003, Pages 903-910

  Coppell, A L ^a   Pei, Q ^a   Zetterstrom T S C ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Antidepressants; Brain derived neurotrophic factor (BDNF); Hippocampus

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DESIPRAMINE; FLUOXETINE; MAPROTILINE; MESSENGER RNA; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; NONHUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0037410392     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00077-7     Document Type: Article

References (35)

1. Ainsworth K., Smith S.E., Zetterström T.S.C., Pei Q., Franklin M., Sharp T. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology. 140:1998;470-477.
2. Amaral D.G., Witter M.P. Hippocampal formation. Paxinos P. The Rat Nervous System, 2nd edn. 1995;443-486 Academic Press.
3. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
4. Altar C. Neurotrophins and depression. Trends Pharmacol. Sci. 20:1999;59-61.
5. Coppell A.L., Zetterström T.S.C. 5-HT mediated regulation of BDNF gene expression. Fund Clin Pharmacology. 38:(Suppl):1999;107.
6. Coppell A.L., Zetterström T.S.C. Biphasic expression of brain-derived neurotrophic factor gene in rat hippocampus following fluoxetine treatment. BR J. Pharmacol. Proc. 129:(Suppl):2000;134.
7. Duman R.S. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry. 44:1998;324-335.
8. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 25:2001;836-844.
9. Ferrer A., Artigas F. Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. Eur J Pharmacol. 263:1994;227-234.
10. Freund T.F., Gulyas A.I., Acsady L., Gores T., Totu K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci USA. 87:1990;8501-8505.
11. Gartside S.E., Umbers V., Hajos M., Sharp T. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol. 115:1995;1064-1070.
12. Hjort S., Bengtson H.J., Kullberg A., Carlzon D., Peilot H., Auerbach S.B. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol. 14:2000;177-185.
13. Khundakar A.A., Mazumdar A., Zetterström T.S.C. Gene expression for brain derived neurotrophic factor in rat hippocampus is reduced by baclophen, tranylcypromine and paroxetine but not flunitrazepam. Br J Pharmacol. 136:(Proc Suppl):2002;57.
14. Khundakar A.A., Zetterström T.S.C. Differential expression of BDNF exons in rat brain after systemic administration of paroxetine and tranylcypromine. Br J Pharmacol. 137:(Proc Suppl):2002;122.
15. Lesch K.P. Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affective Disorders. 62:2001;57-76.
16. Mackowiak M., O'Neill M., Hicks C., Bleakman D., Skolnick P. An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study. Neuropharmacol. 43:2002;1-10.
17. Manier D.H., Shelton R.C., Sulser F. Noradrenergic antidepressants: does chronic treatment increase or decrease nucleaar CREB-P? J Neural Trans. 109:2002;91-99.
18. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J Neurosci. 15:1995;7539-7547.
19. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of camp response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
20. Norrholm S.D., Quimet C.C. Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse. 42:2001;151-163.
21. Pei Q., Burnet P.W.J., Grahame-Smith D.G., Zetterström T.S.C. Differential effects of acute and chronic electroconvulsive shock on the abundance of messanger RNAs for voltage-dependent potassium channel subunits in the rat brain. Neurosci. 78:1997;343-350.
22. Pryor J.C., Sulser F. Evolution of monoamine hypothesis of depression. Horton R.W., Katona C. Biological Aspects of Affective Disorders. 1992;77-94 Academic Press, London.
23. Russo-Neustadt A.A., Beard R.C., Cottman C.W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacol. 21:1999;679-682.
24. Russo-Neustadt A.A., Beard R.C., Huang Y.M., Cottman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience. 101:2000;305-312.
25. Shirayama Y., Chen A.C., Nagakawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. J Neurosci. 22:2002;3251-3261.
26. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R. Antidepressant like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 56:1997;131-137.
27. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNA in the hippocampus. J Neurosci. 15:1995;1768-1777.
28. Timmusk T., Palm K., Metsis M., Reintam T., Paalme V., Saarma M., Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron. 10:1993;475-489.
29. 2 receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci. 17:1997;2785-2795.
30. Wetmore C., Olson L., Bean A.J. Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors. J Neurosci. 14:1994;1688-1700.
31. Zafra F., Castren E., Thoenen H., Lindholm D. Interplay between glutamate and γ-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Soc USA. 88:1991;10037-10041.
32. Zetterström T.S.C., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF compared to a single administration. Mol Brain Res. 57:1998;106-110.
33. Zetterström T.S.C., Pei Q., Ainsworth K., Grahame-Smith D.G. Effects of antidepressant treatments on BDNF gene expression in rat brain. Br J Pharmacol. 123:(Proc Suppl):1998;211.
34. Zetterström T.S.C., McQuade R., Pei Q. Pretreatment with the non-NMDA antagonist DNQX attenuates ECS-induced gene expression for BDNF in rat brain. Br J Pharmacol. 124:(Proc Suppl):1998;69.
35. Zetterström T.S.C., Pei Q., Madhav T.R., Coppell A.L., Grahame-Smith D.G. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology. 38:1999;1063-1073.